India̵7;s Serum Institute is seeking emergency approval in the EU for the Covid Shield.
The move comes amid reports that Covishield is not yet eligible for a green digital certificate. which is a travel card throughout the European Union which will be released on July 1.
Currently, this certificate is for EU citizens only.
Covishield is AstraZeneca’s Vaxzevria jab made in India. which is already authorized in the European Union
Made in India by Serum, the world’s largest vaccine manufacturer.
Vaccines eligible for the Green Pass are currently approved by the European Medicines Agency (EMA).
Serum CEO Adar Poonawalla said Monday his company hopes to “Resolve this issue soon”, citing the fact that Covishield is not yet approved in the EU.
The EMA told the BBC on Monday that the Serum Institute has not yet applied for a permit.
The European Commission has left each member state to decide whether to allow vaccinated travelers. “Allowed at the national level or by the World Health Organization (WHO)”
Covishield was registered for emergency use by the WHO in February.
It is unclear whether the same rules will also apply to foreign tourists visiting the EU.
So far India has had an overwhelming Covishield vaccination, with more than 284 million out of 323 or so vaccinated.
Covaxin, an Indian homegrown vaccine that has not yet been approved by the WHO, has not yet applied for EMA Sputnik 5, the third vaccine to be approved for use in India and by the World Health Organization. It is on the EMA’s list of vaccines under consideration. But it has not launched in India due to supply delays.
At the latest G7 country meeting where India was invited, Dr. Harsh Vardhan, Minister of Health of India, said that India “Strongly against ‘Vaccination passport’ at this juncture.”
The UK’s Equality and Human Rights Commission recently said that introducing a Covid status certificate would discriminate against some groups it said they could create. “A two-tier society where only certain groups can fully enjoy their rights.”